Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Dermatologic 1CNS 1

Conditions

Meningeal Carcinomatosis 7Breast Neoplasms 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Astrocytoma 3Neoplastic Cells, Circulating 2Glioma 2Brain Neoplasms 2Oligodendroglioma 1Neoplasm Recurrence, Local 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma, Follicular 1

Interventions

Trastuzumab 2Radiotherapy 2Capecitabine 2tucatinib 1sapanisertib 1pertuzumab 1patritumab deruxtecan 1paclitaxel-Angiopep-2 conjugate 1omburtamab I-131 1fludarabine 1eribulin 1avelumab 1WP 744 1Temozolomide 1Spinal Puncture 1Rituximab 1Psychiatric Rehabilitation 1Phlebotomy 1Methotrexate 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1AZD1390 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Spinal Puncture × CNS × Clear all
NCT05257967 2025-02-11

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

British Columbia Cancer Agency

Phase NA Recruiting
10 enrolled
CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡